Spherix (SPEX)
Spherix Beneish M-Score: -1.989
View SPEX Beneish M-Score with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
SPEX Beneish M-Score Rankings
| Overall | 14th percentile | 3211 of 3771 |
| Sector | 20th percentile | 273 of 343 in Healthcare |
| Industry | 9th percentile | 19 of 21 in Medical Laboratories & Research |
SPEX Beneish M-Score Range, Past 5 Years
| Minimum | -10.52 | Dec 2007 |
| Maximum | 2.762 | Dec 2008 |
| Average | -3.255 |
About Beneish M Score
The Beneish M Score helps to uncover companies who are likely to be manipulating their reported earnings. Companies with a higher score are more likely to be manipulators. This is a probabilistic model, so it will not detect manipulators with 100% accuracy.
The best cut-off point depends on the costs mistakenly classifying in one of two ways:
1) Classifying firm that is manipulating earnings as a non-manipulator (Type I error), and
2) Classifying a firm as a manipulator when it actually was not manipulating (Type II Error).
Here are optimal cut-offs according to Beneish, presented as the score followed by the cost of Type I error relative to cost of Type II error):
M Score HTML Table:
| Score | Relative Error Costs (Type I:Type II) |
|---|---|
| M Score > -1.49 | (10:1) | M Score > -1.78 | (20:1) | M Score > -1.89 | (40+:1) |
Beneish excluded financial institutions from his sample when calculating the M-Score, so extreme care should be taken when looking at M-Scores of financial firms - their business models are different from the manufacturing and other service firms that Beneish used in his study.
If you want more details, here is the original Beneish M Score Paper, or you can learn about our calculation by clicking "Learn More" below.
Learn More
You may also be interested in these SPEX related companies
SPEX News
Reminder: Spherix to Hold Business Update Conference Call April 11 at 1:00 p.m. Eastern Time
Apr 10, 11:05AM PR Newswire
Apr 10, 11:05AM PR Newswire
RT @idrinkchai $SPEX might holy grail here on intraday, what do you mean by that
about 86 days ago by allars
about 86 days ago by allars
Spherix (SPEX) Rips After Positive SPX-106T Data on Atherosclerotic Plaque Reduction
Mar 07, 10:19AM Street Insider
Mar 07, 10:19AM Street Insider
SPX-106T Arrests Development of Atherosclerotic Plaques in Mouse Model of Cardiovascular Disease
Mar 07, 9:15AM PR Newswire
Mar 07, 9:15AM PR Newswire
Spherix to Present at the LHA Life Sciences & Medical Technologies Virtual Conference on February 16
Feb 10, 10:42AM PR Newswire
Feb 10, 10:42AM PR Newswire
Spherix $SPEX Shares Halted on Breaker Down 22% Following $1.15M Offering
about 120 days ago by Street_Insider
about 120 days ago by Street_Insider
Spherix (SPEX) Shares Halted on Breaker Down 22% Following $1.15M Offering
Feb 02, 2:48PM Street Insider
Feb 02, 2:48PM Street Insider
Shares of Spherix Inc. (SPEX) Trade Up 40% on SPX-106 28-day Rat Toxicology Study Results
Jan 11, 11:51AM Street Insider
Jan 11, 11:51AM Street Insider
Spherix Announces Successful Completion of Important Toxicology Study of SPX-106
Jan 11, 9:47AM PR Newswire
Jan 11, 9:47AM PR Newswire
Spherix Issues Reminder of Business Update Conference Call Set for Today at Noon Eastern Time
Nov 16, 10:03AM PR Newswire
Nov 16, 10:03AM PR Newswire
$SPEX http://stks.co/9tx Showed they could reduce cholesterol levels in mice
about 266 days ago by Tr8r_x
about 266 days ago by Tr8r_x
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SPEX | 0.75 | -0.03 | -3.85% | 3.12M |
| SPCHB | 1.716 | +0.03 | +1.54% | 3.054M |
| SPCHA | 1.22 | -0.15 | -10.95% | 15.14M |
| SPBC | 12.85 | +0.00 | +0.00% | 22.23M |
| SPB | 33.15 | -1.37 | -3.97% | 1.787B |
| SPAR | 4.21 | -0.29 | -6.44% | 151.29M |
| SPAN | 17.51 | +0.01 | +0.06% | 51.10M |
| SPAB | 1.07 | +0.04 | +3.88% | |
| YGE | 2.71 | +0.11 | +4.23% | 378.53M |
| YELP | 15.59 | -1.12 | -6.70% |
